These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3144215)

  • 1. Research initiatives in the immunology of tuberculosis. American Thoracic Society Committee on Priorities for Tuberculosis Research.
    Am Rev Respir Dis; 1988 Nov; 138(5):1327-9. PubMed ID: 3144215
    [No Abstract]   [Full Text] [Related]  

  • 2. Reconsidering the Optimal Immune Response to
    Tezera LB; Mansour S; Elkington P
    Am J Respir Crit Care Med; 2020 Feb; 201(4):407-413. PubMed ID: 31657633
    [No Abstract]   [Full Text] [Related]  

  • 3. Rational design of vaccines against tuberculosis directed by basic immunology.
    Reece ST; Kaufmann SH
    Int J Med Microbiol; 2008 Jan; 298(1-2):143-50. PubMed ID: 17702652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunology of tuberculosis].
    Tokunaga T
    Kekkaku; 1982 Sep; 57(9):455-65. PubMed ID: 6816977
    [No Abstract]   [Full Text] [Related]  

  • 5. Rational design of novel antibacterial vaccines with an emphasis on tuberculosis.
    Kaufmann SH
    Scand J Infect Dis; 2008; 40(8):595-600. PubMed ID: 18979596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding the biology of 16 kDa antigen of Mycobacterium tuberculosis: scope in diagnosis, vaccine design and therapy.
    Siddiqui KF; Amir M; Agrewala JN
    Crit Rev Microbiol; 2011 Nov; 37(4):349-57. PubMed ID: 21919701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serological diagnosis of tuberculosis using IgA detection against the mycobacterial kp-90 antigen.
    Yew WW; Wong CF; Chan CY; Cheung SW; Cheng AF
    Int J Tuberc Lung Dis; 2001 Jun; 5(6):585-6. PubMed ID: 11409590
    [No Abstract]   [Full Text] [Related]  

  • 8. [Advance in DNA vaccine against Mycobacterium tuberculosis].
    Wang BL; Wang HH
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Nov; 27(11):787-90. PubMed ID: 15634398
    [No Abstract]   [Full Text] [Related]  

  • 9. Simplified deoxypropionate acyl chains for Mycobacterium tuberculosis sulfoglycolipid analogues: chain length is essential for high antigenicity.
    Gau B; Lemétais A; Lepore M; Garcia-Alles LF; Bourdreux Y; Mori L; Gilleron M; De Libero G; Puzo G; Beau JM; Prandi J
    Chembiochem; 2013 Dec; 14(18):2413-7. PubMed ID: 24174158
    [No Abstract]   [Full Text] [Related]  

  • 10. Counting antigen-specific T cells: a new approach for monitoring response to tuberculosis treatment?
    Lalvani A
    Clin Infect Dis; 2004 Mar; 38(5):757-9. PubMed ID: 14986263
    [No Abstract]   [Full Text] [Related]  

  • 11. The significance of proteins actively secreted by Mycobacterium tuberculosis in relation to immunity and complications of mycobacterial diseases.
    Harboe M
    Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):470-6. PubMed ID: 1474286
    [No Abstract]   [Full Text] [Related]  

  • 12. The immune response to Mycobacterium tuberculosis.
    Munk ME; Kaufmann SH
    Behring Inst Mitt; 1991 Feb; (88):27-35. PubMed ID: 1904709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New multistage TB vaccine shown to produce stronger, longer-lasting response against Mycobacterium tuberculosis.
    Immunotherapy; 2011 Mar; 3(3):309. PubMed ID: 21395372
    [No Abstract]   [Full Text] [Related]  

  • 14. B lymphocytes from patients with tuberculosis exhibit hampered antigen-specific responses with concomitant overexpression of interleukin-8.
    Vani J; Shaila MS; Rao MK; Krishnaswamy UM; Kaveri SV; Bayry J
    J Infect Dis; 2009 Aug; 200(3):481-2; author reply 482-4. PubMed ID: 19569966
    [No Abstract]   [Full Text] [Related]  

  • 15. [Progress and prospects of tuberculosis immunology and immunogenetics].
    Litvinov VI; Moroz AM; Gergert VI
    Probl Tuberk; 1996; (6):14-8. PubMed ID: 9019757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of RD 1-encoded mycobacterial antigens in the immunodiagnosis of pulmonary, extrapulmonary, and latent tuberculosis infections.
    Katti MK
    J Infect Dis; 2001 Dec; 184(11):1497-8. PubMed ID: 11709800
    [No Abstract]   [Full Text] [Related]  

  • 17. The knowns and unknowns of the immunopathogenesis of tuberculosis.
    Ottenhoff TH
    Int J Tuberc Lung Dis; 2012 Nov; 16(11):1424-32. PubMed ID: 23044443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral T cell interferon-gamma responses and latent tuberculosis.
    Dheda K; Rook G; Zumla A
    Am J Respir Crit Care Med; 2004 Jul; 170(1):97-8; author reply 98. PubMed ID: 15220126
    [No Abstract]   [Full Text] [Related]  

  • 19. The isolation from romanian BCG substrain of non cross reacting antigens to Mycobacterium tuberculosis H37Rv strain.
    Niculescu D; Stavri D; Stavri H; Claiciu I; Bărbulescu R
    Arch Roum Pathol Exp Microbiol; 1983; 42(2-3):213-9. PubMed ID: 6424629
    [No Abstract]   [Full Text] [Related]  

  • 20. Development of vaccines against tuberculosis.
    Tyagi AK; Nangpal P; Satchidanandam V
    Tuberculosis (Edinb); 2011 Sep; 91(5):469-78. PubMed ID: 21334259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.